Deva Holding AS | DEVA - 流动资产



金融业
股票价格
TRY
资产
TRY 12.93B
现金及等价物
TRY 775.92M
销售成本
TRY 991.13M
流动资产
TRY 9.13B
流动负债
TRY 6.43B
债务
TRY 5.3B
股息收益率
0.18
EBIT
TRY 820.88M
EBITDA
TRY 882.9M
EPS每股收益
TRY 2.92
股本和储备
TRY 5.79B
销售毛利
TRY 1.32B
债务利息支出
TRY 272.53M
贷款资金
TRY 559.97M
市值
TRY 14.26B
净收入
TRY 583.98M
营业费用
TRY 1.35B
营业利润
TRY 964.87M
普通股股本
TRY 200.02M
PE价格收益
6.55
销售收入
TRY 2.32B
销售和管理费用
TRY 462.26M
贸易债权人
TRY 809.81M
应收帐款人
TRY 3.03B


流动资产 更改 日
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 1.99M 697K 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Moderna USD 5.77B 774M 2026-03
Organon & Co USD 4.93B 580M 2026-03
Revvity USD 2.13B 111.43M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03